Use of newly established human cell line (SU-CCS -1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma
Epstein A.L., Martin A.O., Kempson R. Use of newly established human cell line (SU-CCS -1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res. 1984, 44:1265-1274.
Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene
Hiratsuka J., et al. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene. Melanoma Res. 2000, 10:297-302.
Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus
Kiyozuka Y., et al. Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus. Cancer Genet. Cytogenet. 2001, 127:7-15.
Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound
Mishima Y., et al. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 1989, 12:388-389.
Melanoma and nonmelanoma neutron capture therapy using gene therapy: overview
Elsevier, Medicine and physics
Mishima Y. Melanoma and nonmelanoma neutron capture therapy using gene therapy: overview. Advances in Neutron Capture Therapy 1997, vol. 1:10-25. Elsevier, Medicine and physics.
Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene
Moritake H., et al. Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene. Cancer Genet. Cytogenet. 2002, 135:48-56.